[{"id":"bc1648bd-c73f-49a2-a8f6-094d16cc301b","acronym":"","url":"https://clinicaltrials.gov/study/NCT05660369","created_at":"2022-12-21T14:58:50.595Z","updated_at":"2024-07-02T16:35:14.877Z","phase":"Phase 1","brief_title":"CARv3-TEAM-E T Cells in Glioblastoma","source_id_and_acronym":"NCT05660369","lead_sponsor":"Marcela V. Maus, M.D.,Ph.D.","biomarkers":" MGMT","pipe":" | ","alterations":" EGFR amplification • EGFRvIII mutation","tags":["MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR amplification • EGFRvIII mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CARv3-TEAM-E T cells"],"overall_status":"Recruiting","enrollment":" Enrollment 21","initiation":"Initiation: 03/22/2023","start_date":" 03/22/2023","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 06/01/2026","study_completion_date":" 06/01/2026","last_update_posted":"2024-03-13"}]